Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Anavex projects EMA feedback on Alzheimer's drug by year-end 2025
Bishop asked about upcoming events. Missling outlined the anticipated schizophrenia trial readout for ANAVEX 3-71 in the first half of 2025, the detailed ATTENTION-AD data presentation in April, and ...
Ethereum Price Forecast: ETH risks a decline to $2,200 as long-term holders increase selling pressure
Ethereum (ETH) declined by 2% on Tuesday due to increased selling activity from long-term holders (LTHs) and a buy-the-dip ...
Ethereum Price Forecast: ETH could see increased volatility as CME shorts soar to record highs
Ethereum (ETH) gained 2% on Monday despite investors' increased Chicago Mercantile Exchange (CME) short positions on the top altcoin. The high shorts have led to speculation of a potential short ...
Finbold | Finance in Bold5d
What’s happening with EUR/USD, as the euro approaches dollar parity
The euro is nearing a dollar parity once again, showing weakness as Donald Trump’s trade war continues with worldwide tariffs ...
Japanese Yen and Aussie Dollar News: Trump’s Tariff Plans in the Spotlight
Japan’s shrinking surplus pressures the yen, boosting USD/JPY. Traders eye US inflation expectations, which may impact Fed ...